A portal venous 5-aminoimidazole-4-carboxamide-1-␤-D-ribofuranoside infusion that results in hepatic 5-aminoimidazole-4-carboxamide-1-␤-D-ribosyl-5-monophosphate (ZMP) concentrations of ϳ4 mol/g liver increases hepatic glycogenolysis and glucose output. ZMP is an AMP analog that mimics the regulatory actions of this nucleotide. The aim of this study was to measure hepatic AMP concentrations in response to increasing energy requirements to test the hypothesis that AMP achieves concentrations during exercise, consistent with a role in stimulation of hepatic glucose metabolism. Male C57BL/6J mice (27.4 Ϯ 0.4 g) were subjected to 35 min of rest [sedentary (SED), n ϭ 8], underwent short-term (ST, 35 min) moderate (20 m/min, 5% grade) exercise (n ϭ 8), or underwent treadmill exercise under similar conditions but until exhaustion (EXH, n ϭ 8). Hepatic AMP concentrations were 0.82 Ϯ 0.05, 1.17 Ϯ 0.11, and 2.52 Ϯ 0.16 mol/g liver in SED, ST, and EXH mice, respectively (P Ͻ 0.05). Hepatic energy charge was 0.66 Ϯ 0.01, 0.58 Ϯ 0.02, and 0.33 Ϯ 0.22 in SED, ST, and EXH mice, respectively (P Ͻ 0.05). Hepatic glycogen was 11.6 Ϯ 1.0, 8.8 Ϯ 2.2, and 0.0 Ϯ 0.1 mg/g liver in SED, ST, and EXH mice, respectively (P Ͻ 0.05). Hepatic AMPK (Thr 172 ) phosphorylation was 1.00 Ϯ 0.14, 1.96 Ϯ 0.16, and 7.44 Ϯ 0.63 arbitrary units in SED, ST, and EXH mice, respectively (P Ͻ 0.05). Thus exercise increases hepatic AMP concentrations. These data suggest that the liver is highly sensitive to metabolic demands, as evidenced by dramatic changes in cellular energy indicators (AMP) and sensors thereof (AMP-activated protein kinase). In conclusion, AMP is sensitively regulated, consistent with it having an important role in hepatic metabolism.
adenosine 5Ј-monophosphate; adenosine 5Ј-monophosphate-activated protein kinase; glycogen ALMOST ALL CELLULAR PROCESSES are coupled to ATP breakdown, giving critical importance to the pathways that maintain appropriate ratios of AMP and ATP. It is not surprising that the cell has evolved sensitive mechanisms to detect, regulate, and compensate for changes in their levels. AMP-activated protein kinase (AMPK) is one such mechanism that acts to prevent deficits in energy metabolism during metabolic stresses, including exercise (9, 10, 23, 31, 33) . AMP is well known to regulate, in addition to AMPK, other enzyme reactions that act to preserve cellular energy charge, including both liver (13, 14) and muscle (26) glycogen phosphorylase and fructose-1,6-bisphosphatase (22) . It was recently shown that the intraportal infusion (1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) of the purine nucleotide precursor 5-aminoimidazole-4-carboxamide-1-␤-D-ribofuranoside (AICAR) potently stimulates the breakdown of liver glycogen (5, 6, 24) . Two aspects of this work were particularly noteworthy. First, AICAR-induced hepatic glycogen breakdown is AMPK independent because it occurs in the presence of marked hyperinsulinemia that suppresses the activation of AMPK (5) . Second, the AICAR infusion was considerably less than previously used in vivo, creating hepatic 5-aminoimidazole-4-carboxamide-1-␤-D-ribosyl-5-monophospate (ZMP, an AMP analog) concentrations of ϳ4 mol/g liver. This concentration of ZMP is comparable to AMP concentrations that stimulate purified glycogen phosphorylase (14, 21, 27) .
It is clear from the discussion above that AICAR at low doses increases hepatic ZMP concentrations and glycogen breakdown. It is unknown, however, whether hepatic AMP and ATP concentrations are affected by physiological conditions, such as exercise, and might therefore be significant physiological regulators of hepatic glycogen metabolism. The hypothesis tested in the present study was that the metabolic demands on the liver during muscular work result in an AMP signal of sufficient magnitude to stimulate hepatic glycogen mobilization, and is therefore an important physiological regulator of the process.
RESEARCH DESIGN AND METHODS

Animals.
Procedures were approved by the Vanderbilt University Animal Care and Use Committee. Twenty-four male C57BL/6J (27.4 Ϯ 0.4 g) mice were purchased from Jackson Laboratories. Mice were housed in a temperature-controlled environment with a 12:12-h light-dark cycle and fed a standard ad libitum diet. Mice were studied at 10 wk of age.
Experiments. Mice were fasted for 5 h before experiments. For exercise experiments, mice were acclimated to a treadmill running with a single, 10-min bout of exercise (20 m/min, 5% grade). One group of mice remained sedentary (SED) within the treadmill for 35 min (n ϭ 8). A second group of mice underwent short-term (ST, 35 min), moderate (20 m/min, 5% grade) exercise (n ϭ 8). A third group of mice exercised under similar treadmill conditions until exhaustion (EXH, n ϭ 8; time to exhaustion was 84 Ϯ 12 min). Mice were defined as exhausted if they remained on the shock grid placed at the end of the treadmill (1.5 mA, 200-ms pulses, 4 Hz) for five continuous seconds. Mice were killed by cervical dislocation, and livers and gastrocnemius muscles were excised (within 30 and 45 s, respectively), freeze-clamped in liquid nitrogen, and stored at Ϫ70°C until future analysis.
Tissue analyses. Tissue adenine nucleotide concentrations were determined from liver and muscle samples homogenized in 0.4 M perchloric acid/0.5 mM EGTA and neutralized with 0.5 M potassium carbonate (pH 6.8). HPLC analysis and UV detection were performed to assess nucleotide levels, as described previously (1, 34) .
Approximately 50 mg of liver samples were homogenized in a solution containing 10% glycerol, 20 mM Na-pyrophospate, 150 mM NaCl, 50 mM HEPES (pH 7.5), 1% NP-40, 20 mM ␤-glycerophosphate, 10 mM NaF, 2 mM EDTA (pH 8.0), 2 mM PMSF, 1 mM CaCl 2, 1 mM MgCl2, 10 g/ml aprotinin, 10 g/ml leupeptin, 2 mM Na2VO3, and 3 mM benzamide. Homogenized samples were assayed for protein concentration using a Pierce bicinchoninic acid protein assay kit (Rockford, IL). Thirty micrograms of protein were run on an SDS-PAGE gel and transferred to a polyvinylidene difluoride membrane. Equal protein loading was confirmed by staining membranes with 0.1% Ponceau S in 5% acetic acid and rinsing with deionized water. Membranes were treated with rabbit ␣-phospho-AMPK (Thr 172 ; Cell Signaling, Beverly, MA) and then incubated with ␣-rabbit-horseradish peroxidase (Promega, Madison, WI). Chemiluminescence was detected with a WesternBreeze kit from Invitrogen (Carlsbad, CA). Densitometry was performed using Scion Image (Frederick, MD) software. Liver glycogen was determined as described previously (6) .
Calculations. Energy charge was calculated by the following equation:
, where AMP, ADP, and ATP are the respective tissue concentrations (2) .
Statistical analysis. Statistical comparisons between groups were made using one-way ANOVA. These were followed by the Fisher least significant difference test for post hoc comparisons. Statistics are reported in figures. Data are presented as means Ϯ SE. Statistical significance was defined as P Ͻ 0.05.
RESULTS
Tissue adenine nucleotides and energy charge. Liver AMP and ATP concentrations were significantly increased (0.82 Ϯ 0.05 to 1.17 Ϯ 0.11 mol/g liver) and decreased (2.42 Ϯ 0.09 to 1.94 Ϯ 0.14 mol/g liver), respectively, in ST vs. SED ( Fig.  1 , P Ͻ 0.05). Liver AMP and ATP concentrations were further increased (2.52 Ϯ 0.16 mol/g liver) and decreased (0.78 Ϯ 0.10 mol/g liver), respectively, in EXH (P Ͻ 0.05, compared with ST and SED). Liver ADP concentrations were not affected by exercise. Five mice were killed by cervical dislocation, and the time between death and freeze-clamping was varied. Liver AMP, ADP, and ATP were not significantly different at 30, 60, 90, or 150 s after cervical dislocation (data not shown). Gastrocnemius AMP concentrations were significantly increased (0.08 Ϯ 0.01 and 0.11 Ϯ 0.02 vs. 0.04 Ϯ 0.01 mol/g muscle) in ST and EXH vs. SED (P Ͻ 0.05; Fig. 2 ). Neither gastrocnemius ADP nor ATP concentrations were affected by exercise. Hepatic energy charge was significantly decreased (0.66 Ϯ 0.01 to 0.58 Ϯ 0.02) in ST vs. SED (P Ͻ 0.05; Fig. 3 ). Hepatic energy charge was further decreased (P Ͻ 0.05) in EXH (0.33 Ϯ 0.02). Energy charge was unaffected by exercise in gastrocnemius.
Liver AMPK phosphorylation and glycogen. Liver AMPK (Thr 172 ) phosphorylation was significantly increased in ST vs. SED (P Ͻ 0.05; Fig. 4A ). Liver AMPK (Thr 172 ) phosphorylation was further increased in EXH (P Ͻ 0.05). Liver glycogen was significantly decreased in ST vs. SED (P Ͻ 0.05; Fig. 4B ). Liver glycogen was essentially depleted in EXH.
DISCUSSION
The results of the present study show that 35 min of moderate exercise results in a deficit in energy status of the liver as defined by increased hepatic AMP concentrations and decreased ATP concentrations. When mice were exercised to exhaustion, hepatic AMP and ATP concentrations were significantly increased and decreased further. At the same time, changes in muscle adenine nucleotides were considerably less or undetectable. A comparison of changes in liver and muscle adenine nucleotide concentrations shows that the energy status of the liver is much more sensitive to changes in metabolic demand than that of the muscle.
Hepatic AMP concentrations in EXH were similar to hepatic concentrations of ZMP obtained in the dog that received an intraportal AICAR infusion. These hepatic ZMP levels markedly stimulate glycogen breakdown and glucose release from the liver despite basal glucagon, hyperinsulinemia, and euglycemia (6) . Subsequent studies (5) have shown that pharmacological insulin levels prevent ZMP-induced AMPK activation but not glycogen breakdown. AMP and ZMP have been shown (14, 21, 27) to activate glycogen phosphorylase directly via allosteric mechanisms. AMPK phosphorylates (8) and inactivates glycogen synthase as well (32) . The AMP values attained with ST (1.7 mM) and exhaustive (3.6 mM) exercise are within the range of AMP/ZMP concentrations (0.05-5 mM) shown to allosterically activate glycogen phosphorylase (14, 21, 27) .
The body aggressively protects arterial glucose concentrations from falling during exercise despite increased muscle glucose uptake by stimulating the release of glucose from the liver (4, 29, 30) . The increases in endogenous glucose production in the dog during exercise (4) and a 1 mg⅐kg Ϫ1 ⅐min
Ϫ1
intraportal AICAR infusion (6) are similar. Clearly, one must be cautious in comparing the species. However, it is interesting to note that the levels in ZMP that cause an increase in glucose production are similar to AMP levels that occur during exercise, albeit in the mouse. Hepatic AMP concentrations were increased 1.4-and 2.1-fold in ST and EXH mice, respectively. A novel finding of these studies is that hepatic AMPK (Thr 172 ) phosphorylation was increased 2-and 6.4-fold in ST and EXH mice, respectively (Fig. 4) . These findings are consistent with earlier studies (9, 23) showing that exercise significantly increased AMPK activity (phosphorylation was not measured). The difference in the increases in AMP concentrations and AMPK phosphorylation reflect AMP's effects on multiple enzymes in regulation of AMPK phosphorylation (12, 15, 16, 20) . AMPK is activated allosterically by an increase in AMP concentration (7, 15) , as well as covalently by phosphorylation of a threonine residue (Thr 172 ) by an upstream kinase, AMPKK/LKB1 (15, 20) . Covalent modification is also dependent on AMP in that 1) binding of AMP to AMPK makes it a better substrate for AMPKK/LKB1 (16), and 2) binding of AMP to AMPK makes it a poor substrate for protein phosphatases (12) . The sensitivity of the liver in detecting energy status is exemplified by exaggerated changes in AMPK phosphorylation compared with changes in AMP.
Recent work has also shown a role for increased cAMP concentrations, which are increased during exercise due to rises in both glucagon and catecholamines, in the regulation of AMPK (Thr 172 ) phosphorylation. Kimball et al. (19) showed that activation of cAMP-dependent protein kinase (PKA) by glucagon is associated with the phosphorylation of LKB1 as well as phosphorylation of AMPK on Thr 172 in rat liver. The link between PKA and AMPK is also supported by a study in adipocytes that shows that activation of PKA using forskolin, isoproteronol, or cAMP analogs results in AMPK (Thr 172 ) phosphorylation (35) . Finally, cAMP-specific phosphodiesterases have been shown to be expressed in liver and activated by hormones that increase cAMP concentrations (18, 28) , which would in turn increase AMP and AMPK phosphorylation. Future studies will be informative in testing the link between glucagon action and hepatic AMP concentrations.
Short-term and exhaustive exercise modestly, yet significantly, increased gastrocnemius AMP concentrations (Fig. 2) to similar concentrations seen in electrically stimulated gastrocnemius (17) . However, in contrast to the liver, gastrocnemius ATP concentrations were rigorously protected from changing with energy requirement, as has been previously shown (3, 11, 33) . The protection of muscle ATP levels results from the presence of the creatine-phosphate/kinase system and increased mitochondrial respiratory capacity (25) .
Results from these studies (11, 17, 31) and ones performed previously show that exercise increases muscle AMP concentrations. This increase has been proposed to have important regulatory ramifications, activating AMPK and increasing translocation of glucose transporter 4. The intriguing novel findings of the present study are that AMP concentrations increase in the liver, as well during exercise, corresponding with increasing energy requirements. Remarkably, the increase in hepatic AMP during exercise dwarfs that seen in the working muscle. The changes in the cellular energy indicator, AMP (as well as ATP), are reflected by changes in energy charge and phosphorylation of the cellular energy sensor, AMPK. In conclusion, the data are consistent with the concept that the liver is highly sensitive (even more so than muscle) to changes in metabolic demands and that adenine nucleotides are candidate-signaling molecules involved in hepatic glucose production during a condition such as exercise.
GRANTS
This work was funded by National Institute of Diabetes and Digestive and Kidney Diseases Grant No. RO1 DK-50277 and, to the Mouse Metabolic Phenotyping Center, U24 DK-59637.
